DMD Bio-Rad Microplate Reader

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on October 19, 2004; DOI: 10.1124/dmd.104.001024


0090-9556/05/3301-182-189$20.00
DMD 33:182-189, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.104.001024v1
33/1/182    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Augustine, L. M.
Right arrow Articles by Cherrington, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Augustine, L. M.
Right arrow Articles by Cherrington, N. J.

XENOBIOTIC AND ENDOBIOTIC TRANSPORTER MRNA EXPRESSION IN THE BLOOD-TESTIS BARRIER

Lisa M. Augustine, Robert J. Markelewicz, Jr., Kim Boekelheide, and Nathan J. Cherrington

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona (L.M.A., N.J.C.); and Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (R.J.M., K.B.)

A major function of xenobiotic and endobiotic transporters is to move a wide range of organic substances across cell membranes. Sertoli cells play an important role in protecting developing germ cells by forming a physiological barrier, limiting exposure to potentially toxic substrates, or conversely, facilitating uptake of xenobiotics within the testis. The aim of this study was to quantitatively determine the constitutive expression of various transporters in isolated Sertoli cells from adult Sprague-Dawley rats. The following mRNA levels were measured in isolated Sertoli cells by the branched DNA signal amplification method, multidrug resistance (Mdr) protein 1a, 1b, and 2; multiple drug resistance protein (Mrp) 1, 2, 3, 4, 5, 6, 7, and 8; sodium taurocholate cotransporting polypeptide; bile salt excretory protein; ileal bile acid transporter; AbcG5 and AbcG8; organic anion transporting polypeptide (Oatp) 1, 2, 3, 4, 5, 9, and 12; prostaglandin transporter (Pgt); testis-specific transporter (Tst) 1 and Tst2; organic anion transporter (Oat) 1, 2, 3, and K; organic cation transporter (Oct) 1, 2, 3, N1, and N2; divalent metal transporter (Dmt) 1, Menke's, and Wilson's; zinc transporter (Znt) 1; equilibrative nucleoside transporter (Ent) 1 and 2; concentrative nucleoside transporter (Cnt) 1 and 2; and peptide transporter (Pept) 1 and 2. Levels were also determined in whole testis, liver, kidney, and ileum to provide a reference for determining relative expression levels. Mrp8, Tst1 and 2, and Ent1 and 2 were expressed in Sertoli cells at higher levels than in liver, kidney, or ileum, whereas Mrp1, 5, and 7, Mdr2, Oatp3, Oat2, OctN2, Dmt1, Menke's, Wilson's, and Znt1 were all significantly expressed in Sertoli cells, but Sertoli cell expression was not the tissue of highest expression. The remaining transporters were expressed at low levels in isolated Sertoli cells. Additionally, expression levels of Mrp1, Mrp7, Mrp8, Tst1, Tst2, OctN2, Wilson's, Znt1, Ent1, and Ent2 were greater in isolated Sertoli cells than in whole testis. Constitutive expression of transporters in Sertoli cells may provide an insight into the range of xenobiotics that can potentially be transported by Sertoli cells and thereby provide a mechanistic under standing of blood-testis barrier function.


Address correspondence to: Dr. Nathan J. Cherrington, University of Arizona, 1703 E. Mabel, Tucson, AZ 85721. E-mail cherrington{at}pharmacy.arizona.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. Enokizono, H. Kusuhara, A. Ose, A. H. Schinkel, and Y. Sugiyama
Quantitative Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting Brain and Testis Penetration of Xenobiotic Compounds
Drug Metab. Dispos., June 1, 2008; 36(6): 995 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. J. Martin, H. Chen, X. Liao, H. Allayee, D. M. Shih, G. S. Lee, D. N. Hovland Jr, W. A. Robbins, K. Carnes, R. A. Hess, et al.
FK506, a Calcineurin Inhibitor, Prevents Cadmium-Induced Testicular Toxicity in Mice
Toxicol. Sci., December 1, 2007; 100(2): 474 - 485.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Hilgendorf, G. Ahlin, A. Seithel, P. Artursson, A.-L. Ungell, and J. Karlsson
Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines
Drug Metab. Dispos., August 1, 2007; 35(8): 1333 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y. Kobayashi, A. Tsuchiya, T. Hayashi, N. Kohyama, M. Ohbayashi, and T. Yamamoto
Isolation and Characterization of Polyspecific Mouse Organic Solute Carrier Protein 1 (mOscp1)
Drug Metab. Dispos., July 1, 2007; 35(7): 1239 - 1245.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Kato, T. Maeda, T. Akaike, and I. Tamai
Characterization of novel Na+-dependent nucleobase transport systems at the blood-testis barrier
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E968 - E975.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
X. Cheng, J. Maher, C. Chen, and C. D. Klaassen
TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)
Drug Metab. Dispos., July 1, 2005; 33(7): 1062 - 1073.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.